Nitric oxide rewires gene expression in the brain, offering new insight into Alzheimer's disease

by Ansley Kelm, University Hospitals Cleveland Medical Center

edited by Sadie Harley, reviewed by Robert Egan

Sadie Harley

Scientific Editor

Meet our editorial team
Behind our editorial process

Robert Egan

Associate Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source

Genes undergo extensive editing through a process called alternative splicing, which greatly increases the size of the functional genome—the working portion of our DNA that helps make each person unique. Put simply, a single gene can be edited in different ways to produce multiple sets of instructions. This helps explain why humans differ so significantly from fruit flies and mice, despite having a similar number of genes.

In a new study, published in Molecular Cell, researchers from University Hospitals and Case Western Reserve University found that nitric oxide—a gas naturally produced in the body—can broadly regulate alternative splicing, dramatically altering how genes function.

"We further showed that nitric oxide levels are decreased in the brains of patients with Alzheimer's disease, and that this loss of control over gene splicing correlates with worse clinical outcomes," said lead author Jonathan Stamler, MD, president and co‑founder of Harrington Discovery Institute at UH and Distinguished University Professor and the Robert S. and Sylvia K. Reitman Family Foundation Chair of Cardiovascular Innovation at the Case Western Reserve School of Medicine.

"In other words, lower nitric oxide levels lead to reduced gene-splicing activity, which is associated with increased plaque buildup and more rapid memory loss."

The research team also found that specific enzymes remove nitric oxide from brain proteins that regulate splicing, creating a nitric oxide–deficient state. The findings suggest that targeting these enzymes could represent a new therapeutic strategy to restore nitric oxide levels in the brain and potentially treat Alzheimer's disease.

"Interestingly, the Alzheimer's field has long believed that nitric oxide levels were too high and contributed to the disease," Dr. Stamler added. "This new discovery changes that paradigm."

Next steps in this research will include studies in animals with new classes of enzyme inhibitors, which should restore nitric oxide in the brain and drive healthy splicing of genes.

The new class of drugs will be developed with the help of the Harrington Discovery Institute at UH, which has a singular mission: To accelerate promising discoveries into medicines for unmet needs.

Publication details

Joseph C. Schindler et al, Nitric oxide drives proteomic diversity through alternative splicing, Molecular Cell (2026). DOI: 10.1016/j.molcel.2026.04.024

Journal information: Molecular Cell

Key medical concepts

Alzheimer's DiseaseNitric OxideAlternative SplicingEnzymes

Clinical categories

NeurologyClinical pharmacologyHealthy aging Provided by University Hospitals Cleveland Medical Center Who's behind this story?

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Nitric oxide rewires gene expression in the brain, offering new insight into Alzheimer's disease (2026, May 22) retrieved 22 May 2026 from https://medicalxpress.com/news/2026-05-nitric-oxide-rewires-gene-brain.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.